Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial 99mTc-DMSA SPECT/CT-Reference-Cited by-同舟云学术

Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial 99mTc-DMSA SPECT/CT

Published:2014-11-26 Issue:1 Volume:9 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Jackson Price,Foroudi Farshad,Pham Daniel,Hofman Michael S,Hardcastle Nicholas,Callahan Jason,Kron Tomas,Siva Shankar

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-014-0253-z.pdf

Reference17 articles.

1. Walsh L, Stanfield JL, Cho LC, C-h C, Forster K, Kabbani W, Cadeddu JA, Hsieh J-T, Choy H, Timmerman R, Lotan Y: Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol. 2006, 50: 795-800. 10.1016/j.eururo.2006.03.021.

2. Ponsky LE, Crownover RL, Rosen MJ, Rodebaugh RF, Castilla EA, Brainard J, Cherullo EE, Novick AC: Initial evaluation of cyberknife technology for extracorporeal renal tissue ablation. Urology. 2003, 61: 498-501. 10.1016/S0090-4295(02)02442-1.

3. Siva S, Pham D, Gill S, Corcoran NM, Foroudi F: A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int. 2012, 110: E737-E743. 10.1111/j.1464-410X.2012.11550.x.

4. Wersäll PJ, Blomgren H, Lax I, Kälkner K-M, Linder C, Lundell G, Nilsson B, Nilsson S, Näslund I, Pisa P, Svedman C: Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol. 2005, 77: 88-95. 10.1016/j.radonc.2005.03.022.

5. Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner K-M, Svedman C: Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol. 2006, 45: 493-497. 10.1080/02841860600604611.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS);The Lancet Oncology;2024-01

2. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?;Clinical Oncology;2023-03

3. Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer;Clinical and Translational Radiation Oncology;2023-03

4. Multi-Scale Temporal Imaging: From Micro- and Meso- to Macro-scale-time Nuclear Medicine;PET Clinics;2023-01

5. SBRT in Localized Renal Carcinoma: A Review of the Literature;Anticancer Research;2022-01-29